Abstract:Background: Lactococcus lactis is widely used as a dairy starter and has been extensively studied. Based on the acquired knowledge on its physiology and metabolism, new applications have been envisaged and there is an increasing interest of using L. lactis as a cell factory. Plasmids constitute the main toolbox for L. lactis genetic engineering and most rely on antibiotic resistant markers for plasmid selection and maintenance. In this work, we have assessed the ability of the bacteriocin Lactococcin 972 (Lcn972) gene cluster to behave as a food-grade post-segregational killing system to stabilize recombinant plasmids in L. lactis in the absence of antibiotics. Lcn972 is a non-lantibiotic bacteriocin encoded by the 11-kbp plasmid pBL1 with a potent antimicrobial activity against Lactococcus. Results: Attempts to clone the full lcn972 operon with its own promoter (P972), the structural gene lcn972 and the immunity genes orf2-orf3 in the unstable plasmid pIL252 failed and only plasmids with a mutated promoter were recovered. Alternatively, cloning under other constitutive promoters was approached and achieved, but bacteriocin production levels were lower than those provided by pBL1. Segregational stability studies revealed that the recombinant plasmids that yielded high bacteriocin titers were maintained for at least 200 generations without antibiotic selection. In the case of expression vectors such as pTRL1, the Lcn972 gene cluster also contributed to plasmid maintenance without compromising the production of the fluorescent mCherry protein. Furthermore, unstable Lcn972 recombinant plasmids became integrated into the chromosome through the activity of insertion sequences, supporting the notion that Lcn972 does apply a strong selective pressure against susceptible cells. Despite of it, the Lcn972 gene cluster was not enough to avoid the use of antibiotics to select plasmid-bearing cells right after transformation. Conclusions: Inserting the Lcn972 cluster into segregational unstable plasmids prevents their lost by segregation and probable could be applied as an alternative to the use of antibiotics to support safer and more sustainable biotechnological applications of genetically engineered L. lactis.

Chlamydomonas reinhardtii-expressed multimer of Bacteriocin LS2 potently inhibits the growth of bacteria

Chlamydomonas reinhardtii-derived multimer Mytichitin-CB possesses potent antibacterial properties

Chlamydomonas reinhardtii -derived Mytichitin-CB/Hispidalin Chimera Efficiently Inhibits the Growth of Bacteria by Disrupting Their Membrane Integrity

Intracellular and Extracellular Expression of Bacillus Thuringiensis Crystal Protein Cry5B in Lactococcus Lactis for Use As an Anthelminthic.

Expression of Anti-Lipopolysaccharide Factor Isoform 3 in Chlamydomonas reinhardtii Showing High Antimicrobial Activity

Green algae-derived triple CATH_BRALE multimer protein potently inhibits bacterial growth by permeabilizing the bacterial cell membrane

Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii

A bacteriocin gene cluster able to enhance plasmid maintenance in Lactococcus lactis

Purification and antimicrobial mechanism of a novel bacteriocin produced by Lactobacillus rhamnosus 1.0320

Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods

Identification of A New Bacillus Licheniformis Strain Producing A Bacteriocin-Like Substance

Partial Purification and Characterization of a Broad‐spectrum Bacteriocin Produced by a Lactobacillus Plantarum Zrx03 Isolated from Infant's Feces

Bacteriocin producing microbes with bactericidal activity against multidrug resistant pathogens

Isolation and Characterization of A Bacteriocin Produced by an Isolated Bacillus Subtilis Lfb112 That Exhibits Antimicrobial Activity Against Domestic Animal Pathogens

Expressing Antimicrobial Peptide Cathelicidin-Bf in Bacillus Subtilis Using Sumo Technology

Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen

Production of Bacteriocin E50-52 by Small Ubiquitin-Related Modifier Fusion in Escherichia Coli.

Expression, Purification and Characterization of a Novel Hybrid Peptide CLP with Excellent Antibacterial Activity

Heterologous Expression of Plantaricin 423 and Mundticin ST4SA in Saccharomyces cerevisiae

Cloning and Expression of Synthetic Genes Encoding the Broad Antimicrobial Spectrum Bacteriocins SRCAM 602, OR-7, E-760, and L-1077, by Recombinant Pichia pastoris

Biosynthesis And Secretion Of Human Tissue Kallikrein In Transgenic Chlamydomonas Reinhardtii